January 30, 2019
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to
Read More
January 30, 2019
Immunogenicity and Safety Study of GSK Biologicals’ GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Read More
January 30, 2019
Immunogenicity and Safety Study of GSK Biologicals’ GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine Administered as a Booster Dose
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine Administered as a Booster Dose
Read More
January 30, 2019
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Read More
January 30, 2019
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Read More
December 10, 2018
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to
Read More
December 10, 2018
Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Read More
X